Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KNC Laboratories, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 6%
6568 KNC Laboratories Co., Ltd. 【J-GAAP】
Earnings ReportKNC Laboratories Co., Ltd. <6568> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The ordinary profit (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2026 (April to December) significantly dropped 65.9% from the same period last year to 165 million yen.
However, the full-year forecast for ordinary profit has been revised upward 6.3%, from the previous forecast of 800 million yen to 850 million yen (compared to 929 million yen in the previous period), and the declining rate is expected to decrease from 13.9% to 8.5%.
Based on the full-year plan announced by the company after the upward revision, our estimate of the ordinary profit for the October to March period (second half) has been revised upward 6.3%, from the previous forecast of 789 million yen to 839 million yen (compared to 843 million yen in the same period of the previous year), and the declining rate is expected to decrease from 6.4% to 0.5%.
In the most recent three-month period, from October to December (3Q), the ordinary profit significantly dropped to 154 million yen, a 61.3% decrease compared to the same period last year. The operating profit margin significantly dropped from 12.7% in the same period last year to 6.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 5,184 | 850 | 864 | 595 | 77.2 | 41.3 | Feb 9, 2024 | J-GAAP |
| Apr - Dec, 2024 | 5,254 | 322 | 484 | 338 | 43.9 | 52.1 | Feb 14, 2025 | J-GAAP |
| Apr - Dec, 2025 | 5,593 | 154 | 165 | 105 | 13.7 | 19.4 | Feb 13, 2026 | J-GAAP |
| YoY | +6.5% | -52.2% | -65.9% | -68.9% | -68.8% |
Guidance Update
Second Half Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2025 Prev | 5,226 | 780 | 789 | 583 | 75.3 | 17 | Nov 14, 2025 | J-GAAP |
| Oct - Mar, 2025 New | 5,426 | 850 | 839 | 599 | 77.4 | 17 | Feb 13, 2026 | J-GAAP |
| Revision Rate | +3.8% | +9.0% | +6.3% | +2.7% | +2.7% |
Full Year Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2026 Prev | 8,600 | 780 | 800 | 584 | 75.4 | 33 | May 13, 2025 | J-GAAP |
| Mar, 2026 New | 8,800 | 850 | 850 | 600 | 77.5 | 33 | Feb 13, 2026 | J-GAAP |
| Revision Rate | +2.3% | +9.0% | +6.3% | +2.7% | +2.7% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 4,856 | 695 | 843 | 683 | 88.4 | 17 | May 13, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 5,426 | 850 | 839 | 599 | 77.4 | 17 | Feb 13, 2026 | J-GAAP |
| YoY | +11.7% | +22.3% | -0.5% | -12.3% | -12.5% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 9,154 | 2,081 | 2,094 | 1,493 | 193.5 | 30 | May 13, 2024 | J-GAAP |
| Mar, 2025 | 8,178 | 771 | 929 | 737 | 95.4 | 33 | May 13, 2025 | J-GAAP |
| Mar, 2026 Guidance | 8,800 | 850 | 850 | 600 | 77.5 | 33 | Feb 13, 2026 | J-GAAP |
| YoY | +7.6% | +10.2% | -8.5% | -18.6% | -18.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 1,932 | 246 | 398 | 284 | 36.8 | 12.7 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 2,924 | 449 | 445 | 399 | 51.7 | 15.4 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 1,694 | -9 | -11 | -11 | -1.5 | -0.5 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 1,680 | 9 | 22 | 12 | 1.6 | 0.5 | Nov 14, 2025 | J-GAAP |
| Oct - Dec, 2025 | 2,219 | 154 | 154 | 104 | 13.5 | 6.9 | Feb 13, 2026 | J-GAAP |
| YoY | +14.9% | -37.4% | -61.3% | -63.4% | -63.3% |
Related Articles
APPLE INTERNATIONAL, 67% Increase in Ordinary Profit for The Current Fiscal Year
ANABUKI KOSAN, First Half Ordinary Profit Increases by 45%, Exceeds Full-Year Plan
TAKEDA iP, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 5%, Oct-Dec Ordinary Profit Decreases by 13%
RIDE ON EXPRESS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 38%, Oct-Dec Ordinary Profit Decreases by 26%
Human Technologies, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 20%
Atlas Technologies, 2.9 times Increase in Ordinary Profit for The Current Fiscal Year
Cominix, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 30%, Oct-Dec Ordinary Profit Increases by 3.2 times
Human Holdings, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2%, Oct-Dec Ordinary Profit Decreases by 17%
NAKAMURA CHOUKOU, Apr-Dec (Cumulative 3Q) Ordinary Profit Recovered to Zero, Oct-Dec Ordinary Profit Turns to Loss
SecuAvail, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Turns to Loss